Mark Caulfield's Biography

Mark Caulfield, Chief Scientist, Queen Mary University of London

Mark graduated in Medicine in 1984 from the London Hospital Medical College and trained in Clinical Pharmacology at St Bartholomew’s Hospital (Barts) where he developed a research programme in molecular genetics of hypertension and clinical research. In 2009 he won the Lily Prize of the British Pharmacology Society.
In 2000 Mark successfully bid for £3.1m to create the Barts and The London Genome Centre at QMUL, underpinning over 40 programmes of research. Since 2008 he has directed the Barts National Institute of Health Research (NIHR) Cardiovascular Biomedical Research Unit. In 2012 he become Co-Chair of NIHR Comprehensive Research Network Cardiovascular Sub-Speciality Group.
Mark was appointed Director of the William Harvey Research Institute in 2002 and was elected to the Academy of Medical Sciences in 2008. Particular areas of research are Cardiovascular Genomics and Translational Cardiovascular Research and Pharmacology.
From 2009 to 2011 Mark was President of the BHS. He also served on the NICE Guideline Group for hypertension and leads the Joint UK Societies’ Working Group and Consensus on Renal Denervation.
In 2013 he became an NIHR Senior Investigator and was appointed as the Chief Scientist for Genomics England (NHS 100K Sequencing Project) 2013-2017.